AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $352,423 | +19.4% | 24,836 | +2.3% | 0.00% | 0.0% |
| Q3 2023 | $295,075 | -22.1% | 24,286 | -19.6% | 0.00% | 0.0% |
| Q2 2023 | $378,872 | +59.9% | 30,189 | +41.3% | 0.00% | 0.0% |
| Q1 2023 | $237,004 | +6.9% | 21,371 | +17.7% | 0.00% | 0.0% |
| Q4 2022 | $221,660 | -99.9% | 18,154 | -13.9% | 0.00% | 0.0% |
| Q3 2022 | $220,054,000 | -20.3% | 21,078 | -18.0% | 0.00% | 0.0% |
| Q2 2022 | $276,221,000 | +4.6% | 25,695 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $263,996,000 | -84.2% | 22,837 | -86.9% | 0.00% | -81.8% |
| Q3 2021 | $1,666,098,000 | +608.9% | 174,278 | +614.8% | 0.01% | +450.0% |
| Q2 2021 | $235,023,000 | -35.3% | 24,380 | +55.0% | 0.00% | -33.3% |
| Q4 2020 | $363,317,000 | -9.9% | 15,728 | -44.9% | 0.00% | -25.0% |
| Q3 2020 | $403,126,000 | -52.9% | 28,550 | -49.7% | 0.00% | -60.0% |
| Q2 2020 | $856,061,000 | – | 56,768 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
| Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
| Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
| Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
| Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
| CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
| Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
| Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
| SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
| Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |